OptimizeRx Launches AI-Powered Real-World Evidence Solution on Its Point-of-Care Platform
01 Dezember 2020 - 1:31PM
OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital
health solutions for life science companies, physicians and
patients, has introduced a transformative enhancement to its
digital health and communications platform.
The new enhancement involves the application of advanced
analytics, using machine-learning methods applied to real-world
data (RWD), resulting in the accurate delivery of therapeutic
support and brand messages to clinicians at critical points in a
patient's care journey.
This use of patient and scenario modeling that optimizes and
automates information delivery at the point-of-care is
unprecedented in the industry.
The solution creates new opportunities for life science
organizations to better support providers as they look to make the
best treatment decisions for their patients, especially for those
with complex dosing requirements or chronic disease indications.
The innovation also enables more messages to be delivered to more
physicians whose actions were not previously visible on the
platform.
"Everyone is trying to solve the problem of siloed health data,"
noted Steve Silvestro, chief commercial officer at OptimizeRx.
“Lack of communication between healthcare systems has created a big
problem for patients and providers, since often they don’t have all
the information they need at crucial moments during the delivery of
care. Democratizing data in this way gives life science
organizations the ability to communicate directly with providers
using an automated, compliant, and data-driven method, and one that
is based on care milestones and a patient’s treatment history.”
A recent analysis by the Partnership for Health IT Patient
Safety reveals how patient outcomes can be impacted by delays and
breakdowns in communication during the care delivery process. This
is especially evident in specialty and oncology medicine, where
OptimizeRx’s RWD evidence-driven approach can help healthcare
providers unlock valuable insights for their patients. It can speed
time-to-diagnoses and care referrals, as well as prevent delays in
treatment and reduce cost in the system, and ultimately allow
patients to have a better overall experience with improved
outcomes.
“The entire healthcare system is focused on data
interoperability in order to deliver the most effective care,” said
Miriam Paramore, OptimizeRx president. “Data alone doesn’t help,
but actionable information does. Given our platform’s access to
real-world-data, such as diagnoses, lab results, and procedure
details, we can apply our ‘secret sauce’ of AI and machine learning
so that the data becomes useful information. We can then deliver
this information at the right time, to the right person, and right
within their daily e-prescribing workflow. This represents a true
breakthrough in our efforts to improve the overall healthcare
system for patients and providers alike.”
About OptimizeRxOptimizeRx is a digital health
company that provides communications solutions for life science
companies, physicians and patients. Connecting over half of
healthcare providers in the US and millions of patients through a
proprietary network, the OptimizeRx digital health platform helps
patients afford and stay on medications. The platform unlocks new
patient and physician touchpoints for life science companies along
the patient journey, from point-of-care, to retail pharmacy,
through mobile patient engagement.For more information, follow the
company on Twitter, LinkedIn or
visit www.optimizerx.com.
Important Cautions Regarding Forward Looking
StatementsThis press release contains forward-looking
statements within the definition of Section 27A of the Securities
Act of 1933, as amended, and such as in section 21E of the
Securities Act of 1934, as amended. These forward-looking
statements should not be used to make an investment decision. The
words 'estimate,' 'possible' and 'seeking' and similar expressions
identify forward-looking statements, which speak only as to the
date the statement was made. The company undertakes no obligation
to publicly update or revise any forward-looking statements,
whether because of new information, future events, or otherwise.
Forward-looking statements are inherently subject to risks and
uncertainties, some of which cannot be predicted, or quantified.
Future events and actual results could differ materially from those
set forth in, contemplated by, or underlying the forward-looking
statements. The risks and uncertainties to which forward-looking
statements are subject include, but are not limited to, the effect
of government regulation, competition, and other material
risks.
Company Contact Doug Baker, CFOTel (248)
651-6568 x807 dbaker@optimizerx.com
Media Contact Maira Alejandra, Media Relations
ManagerTel (754) 245-7070 malejandra@optimizerx.com
Investor Relations Contact Ron Both or Grant
StudeCMA Investor RelationsTel (949) 432-7557 oprx@cma.team
OptimizeRx (NASDAQ:OPRX)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
OptimizeRx (NASDAQ:OPRX)
Historical Stock Chart
Von Jul 2023 bis Jul 2024